Join
Live feed
·
PRReleasevia Quantisnow
PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

ByQuantisnow·Wall Street's wire, on your screen.
PRCT· PROCEPT BioRobotics Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRCT (PROCEPT BioRobotics Corporation) and more on Quantisnow.